to magnetizable cellulose/iron oxide particles. Sodium salicylate is used as a blocking agent to prevent interference from endogenous binding proteins in serum. Serum sample and labeled cortisol are incubated with the antibody-coupled solid phase for 30 mm. The solid phase is then separated and washed to remove free labeled cortisol and endogenous fluorophores of the sample. Finally we elute the antibody-bound fraction of the labeled cortisol into an alkaline methanolic medium and measure its fluorescence. The separation, wash, and elution steps are facilitated by magnetic sedimentation. The assay is suff iciently sensitive, specific, and reliable for routine use and correlates acceptably (r = 0.92) with an established radioimmunoassay. Precision (CV) ranged from 4 to 10% in experiments on three pooled sera; analytical recovery for s#{233}ra supplemented with as much as 360 tg of cortisol per liter was 91 to 109%. hydroxysuccinimide in 1 mL of dimethylformamide, and stir for 1 h. To the resulting active ester add dropwise during 30 mm a solution of 24 mg of fluoresceinthiocarbamyl ethylenediamine in 5 mL of dimethylformamide. Apply the reaction mixture to silica gel sheets as desired (100 sL per sheet) and develop with ethyl acetate/methanol/acetic acid (90/8/2 by vol) to separate one major (R 0.49) and two minor (Rf 0.42 and 0.63) components.
Scrape the area of the major product from the sheet, elute the scrapings with 1 mL of methanol, and store the eluate at -20 #{176}C.
We estimated the concentration of the fluorescein-labeled cortisol product spectrophotometrically, on the assumption that it has the same molar absorptivity at 492 nm as fluorescein itself when diluted in sodium bicarbonate buffer (50 mmol/L, pH 9.0); we determined this to be 8. 
